Ledger.Open graph →
SEC Form D · Amendment · filed May 13, 2022

DOSE Therapeutics, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Steven L. Mcknight · Dallas, TXDirectorJohn F. Murray · Dallas, TXExec · DirectorDeepak F. Nijhawan · Dallas, TXDirectorBlair Lapointe · Dallas, TXDirectorMichael Bakes · Dallas, TXExecMchenry T. Tichenor · Dallas, TXDirectorJatin R. Desai · Atlanta, GADirectorJeffrey Miehe · NEWPORT BEACH, CADirectorChristopher S. O'Connor · Durham, NCDirectorDaniel J. Rodriguez · New York, NYDirectorFrederic Ryser · Louisville, KYExecMaureen K. O'Connor · Durham, NCExec · DirectorRandy Story · Scottsdale, AZDirectorCamille Renshaw · Brooklyn, NYDirectorEdward C. Copelin · Alpharetta, GAExecYaron C. Ashkenazi · Scottsdale, AZDirectorGrant L. Peterson · Alpharetta, GAExec · DirectorRyan 2088 Advisory, LLC · Alpharetta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗